• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活跃的YAP通过LPAR3以有丝分裂磷酸化依赖性方式促进胰腺癌细胞的运动性、侵袭和肿瘤发生。

Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3.

作者信息

Yang Shuping, Zhang Lin, Purohit Vinee, Shukla Surendra K, Chen Xingcheng, Yu Fang, Fu Kai, Chen Yuanhong, Solheim Joyce, Singh Pankaj K, Song Wei, Dong Jixin

机构信息

Department of Oncology, Shandong Provincial Hospital affiliated with Shandong University, Jinan, Shandong, P. R. China.

Eppley Institute for Research in Cancer, Fred and Pamela Buffett Cancer Center, Omaha, NE, USA.

出版信息

Oncotarget. 2015 Nov 3;6(34):36019-31. doi: 10.18632/oncotarget.5935.

DOI:10.18632/oncotarget.5935
PMID:26440309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4742158/
Abstract

The transcriptional co-activator Yes-associated protein, YAP, is a main effector in the Hippo tumor suppressor pathway. We recently defined a mechanism for positive regulation of YAP through CDK1-mediated mitotic phosphorylation. Here, we show that active YAP promotes pancreatic cancer cell migration, invasion and anchorage-independent growth in a mitotic phosphorylation-dependent manner. Mitotic phosphorylation is essential for YAP-driven tumorigenesis in animals. YAP reduction significantly impairs cell migration and invasion. Immunohistochemistry shows significant upregulation and nuclear localization of YAP in metastases when compared with primary tumors and normal tissue in human. Mitotic phosphorylation of YAP controls a unique transcriptional program in pancreatic cells. Expression profiles reveal LPAR3 (lysophosphatidic acid receptor 3) as a mediator for mitotic phosphorylation-driven pancreatic cell motility and invasion. Together, this work identifies YAP as a novel regulator of pancreatic cancer cell motility, invasion and metastasis, and as a potential therapeutic target for invasive pancreatic cancer.

摘要

转录共激活因子Yes相关蛋白(YAP)是Hippo肿瘤抑制通路中的主要效应因子。我们最近确定了一种通过细胞周期蛋白依赖性激酶1(CDK1)介导的有丝分裂磷酸化对YAP进行正向调节的机制。在此,我们表明活性YAP以有丝分裂磷酸化依赖性方式促进胰腺癌细胞的迁移、侵袭和非锚定依赖性生长。有丝分裂磷酸化对于YAP驱动的动物肿瘤发生至关重要。YAP的减少显著损害细胞迁移和侵袭。免疫组织化学显示,与人类原发性肿瘤和正常组织相比,YAP在转移灶中显著上调并定位于细胞核。YAP的有丝分裂磷酸化控制胰腺细胞中独特的转录程序。表达谱显示溶血磷脂酸受体3(LPAR3)是有丝分裂磷酸化驱动的胰腺细胞运动和侵袭的介质。总之,这项研究确定YAP是胰腺癌细胞运动、侵袭和转移的新型调节因子,也是侵袭性胰腺癌的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/10ae4b7e5370/oncotarget-06-36019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/fd2a6f08d27e/oncotarget-06-36019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/e8350732569b/oncotarget-06-36019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/82c89f6eb79b/oncotarget-06-36019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/1bb4d09677d2/oncotarget-06-36019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/ed787151a662/oncotarget-06-36019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/10ae4b7e5370/oncotarget-06-36019-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/fd2a6f08d27e/oncotarget-06-36019-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/e8350732569b/oncotarget-06-36019-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/82c89f6eb79b/oncotarget-06-36019-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/1bb4d09677d2/oncotarget-06-36019-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/ed787151a662/oncotarget-06-36019-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c4/4742158/10ae4b7e5370/oncotarget-06-36019-g006.jpg

相似文献

1
Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3.活跃的YAP通过LPAR3以有丝分裂磷酸化依赖性方式促进胰腺癌细胞的运动性、侵袭和肿瘤发生。
Oncotarget. 2015 Nov 3;6(34):36019-31. doi: 10.18632/oncotarget.5935.
2
Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.刺参酸性黏多糖通过Hippo-YAP信号通路抑制胰腺癌SW1990细胞的增殖。
Oncotarget. 2017 Mar 7;8(10):16356-16366. doi: 10.18632/oncotarget.14633.
3
CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation.CDK1 对 YAP 的磷酸化促进有丝分裂缺陷和细胞迁移,对肿瘤转化是必需的。
Cancer Res. 2013 Nov 15;73(22):6722-33. doi: 10.1158/0008-5472.CAN-13-2049. Epub 2013 Oct 7.
4
Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.缺氧而非常氧通过上调胰腺癌中RBPJ和类MAML3促进Smoothened转录。
Cancer Lett. 2016 Feb 28;371(2):143-50. doi: 10.1016/j.canlet.2015.11.012. Epub 2015 Nov 30.
5
Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.抑制 YAP 表达通过破坏肿瘤-基质相互作用抑制胰腺癌进展。
J Exp Clin Cancer Res. 2018 Mar 27;37(1):69. doi: 10.1186/s13046-018-0740-4.
6
LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma.肿瘤坏死因子-α诱导的LATS2通过磷酸化口腔鳞状细胞癌中的YAP来抑制细胞增殖和侵袭。
J Oral Pathol Med. 2015 Jul;44(6):475-81. doi: 10.1111/jop.12317. Epub 2015 Mar 17.
7
Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.Linc-RoR 通过 Hippo/YAP 通路促进胰腺癌细胞的增殖、迁移和侵袭。
J Cell Biochem. 2020 Jan;121(1):632-641. doi: 10.1002/jcb.29308. Epub 2019 Aug 26.
8
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.MEKK3通过调节YAP和TAZ转录活性维持胰腺癌的上皮-间质转化和干性。
Anticancer Res. 2018 Apr;38(4):1937-1946. doi: 10.21873/anticanres.12431.
9
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.一种新型的HMGA1-CCNE2-YAP轴调节乳腺癌的侵袭性。
Oncotarget. 2015 Aug 7;6(22):19087-101. doi: 10.18632/oncotarget.4236.
10
Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation.Zyxin 通过有丝分裂磷酸化依赖性和 CDK8 介导的 YAP 激活促进结肠癌肿瘤发生。
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6760-E6769. doi: 10.1073/pnas.1800621115. Epub 2018 Jul 2.

引用本文的文献

1
Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches.肿瘤微环境中的机械力:作用、途径及治疗方法。
J Transl Med. 2025 Mar 12;23(1):313. doi: 10.1186/s12967-025-06306-8.
2
Rac1 GTPase Regulates the βTrCP-Mediated Proteolysis of YAP Independently of the LATS1/2 Kinases.Rac1 GTP酶独立于LATS1/2激酶调节βTrCP介导的YAP蛋白水解。
Cancers (Basel). 2024 Oct 25;16(21):3605. doi: 10.3390/cancers16213605.
3
ANKRD1 Promotes Breast Cancer Metastasis by Activating NF-B-MAGE-A6 Pathway.锚蛋白重复结构域1通过激活核因子-κB-黑色素瘤抗原基因A6通路促进乳腺癌转移。

本文引用的文献

1
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.Yap1 激活可绕过胰腺癌中的致癌 Kras 成瘾。
Cell. 2014 Jul 3;158(1):185-197. doi: 10.1016/j.cell.2014.06.003. Epub 2014 Jun 19.
2
Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.河马共激活因子YAP1上调SOX9并赋予食管癌细胞干细胞样特性。
Cancer Res. 2014 Aug 1;74(15):4170-82. doi: 10.1158/0008-5472.CAN-13-3569. Epub 2014 Jun 6.
3
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.
Cancers (Basel). 2024 Sep 27;16(19):3306. doi: 10.3390/cancers16193306.
4
BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis.BUB1通过抑制铁死亡促进胰腺癌细胞对吉西他滨的耐药性。
Cancers (Basel). 2024 Apr 18;16(8):1540. doi: 10.3390/cancers16081540.
5
YAP1 expression in colorectal cancer confers the aggressive phenotypes via its target genes.YAP1 在结直肠癌中的表达通过其靶基因赋予侵袭表型。
Cell Cycle. 2024 Jan;23(1):83-91. doi: 10.1080/15384101.2024.2309017. Epub 2024 Jan 23.
6
TGFβ and Hippo Signaling Pathways Coordinate to Promote Acinar to Ductal Metaplasia in Human Pancreas.TGFβ 和 Hippo 信号通路协同促进人胰腺中的腺泡到导管的化生。
Cells. 2024 Jan 18;13(2):186. doi: 10.3390/cells13020186.
7
ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation.ASPP2在有丝分裂期间被CDK1磷酸化,是胰腺癌细胞增殖所必需的。
Cancers (Basel). 2023 Nov 15;15(22):5424. doi: 10.3390/cancers15225424.
8
Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD-L1 expression in pancreatic cancer.他汀类药物通过JNK信号激活抑制YAP/TAZ表达发挥抗生长作用,并通过下调胰腺癌中PD-L1的表达消除免疫抑制。
Am J Cancer Res. 2023 May 15;13(5):2041-2054. eCollection 2023.
9
gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.胃肠道癌症中的基因与自分泌运动因子-溶血磷脂酸轴
World J Gastrointest Oncol. 2022 Aug 15;14(8):1388-1405. doi: 10.4251/wjgo.v14.i8.1388.
10
Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy.Src 家族激酶对胰腺癌细胞中 YAP 和 ERK 激活的相反作用:对靶向治疗的影响。
Mol Cancer Ther. 2022 Nov 3;21(11):1652-1662. doi: 10.1158/1535-7163.MCT-21-0964.
突变 Gq/11 通过激活 YAP 促进葡萄膜黑色素瘤的发生。
Cancer Cell. 2014 Jun 16;25(6):822-30. doi: 10.1016/j.ccr.2014.04.017. Epub 2014 May 29.
4
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.突变型 KRAS 下游的转录调节因子 YAP 对于胰腺导管腺癌的肿瘤进展是必需的。
Sci Signal. 2014 May 6;7(324):ra42. doi: 10.1126/scisignal.2005049.
5
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.Hippo 通路效应物 TAZ 和 YAP 在发育、稳态和疾病中的作用。
Development. 2014 Apr;141(8):1614-26. doi: 10.1242/dev.102376.
6
Kras as a key oncogene and therapeutic target in pancreatic cancer.Kras作为胰腺癌中的关键癌基因和治疗靶点。
Front Physiol. 2014 Jan 21;4:407. doi: 10.3389/fphys.2013.00407. eCollection 2013.
7
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Hippo 的两面性:针对 Hippo 通路的再生医学和癌症治疗。
Nat Rev Drug Discov. 2014 Jan;13(1):63-79. doi: 10.1038/nrd4161. Epub 2013 Dec 13.
8
Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.丝氨酸苏氨酸激酶(ERK)-核糖体 S6 激酶(RSK)级联磷酸化 KIBRA 调节细胞增殖和迁移。
Cell Signal. 2014 Feb;26(2):343-51. doi: 10.1016/j.cellsig.2013.11.012. Epub 2013 Nov 19.
9
CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation.CDK1 对 YAP 的磷酸化促进有丝分裂缺陷和细胞迁移,对肿瘤转化是必需的。
Cancer Res. 2013 Nov 15;73(22):6722-33. doi: 10.1158/0008-5472.CAN-13-2049. Epub 2013 Oct 7.
10
Regulation of the Hippo pathway and implications for anticancer drug development.Hippo 通路的调控及其在抗癌药物开发中的意义。
Trends Pharmacol Sci. 2013 Oct;34(10):581-9. doi: 10.1016/j.tips.2013.08.006. Epub 2013 Sep 16.